Open · PA-24-253 · CFDA 93.113;93.121;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.310;93.350;93.351;93.352;93.353;93.361;93.393;93.394;93.395;93.396;93.397;93.398;93.399;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879 · Discretionary
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- Varies
- Award range
- Open
- Status
- 353d
- Days left
- -
- Expected awards
The verdict
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) is an open discretionary opportunity from National Institutes of Health, offering Varies by applicant. Applications close in 353 days.
- Varies
- award range
- Open
- 353 days left
- 93.113;93.121;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.310;93.350;93.351;93.352;93.353;93.361;93.393;93.394;93.395;93.396;93.397;93.398;93.399;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Successor-in-Interest (Type 6 Parent Clinical Trial Optional) - is cataloged under number PA-24-253 and tied to CFDA assistance listing 93.113;93.121;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.310;93.350;93.351;93.352;93.353;93.361;93.393;93.394;93.395;93.396;93.397;93.398;93.399;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on July 11, 2024 and last updated on July 16, 2024. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. Applications close on July 17, 2027 - roughly 353 days from today. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
July 17, 2027
Posted
July 11, 2024
Instrument
Grant
Description
The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this NOFO. Applications for change of recipient organization status are considered prior approval requests (as described in Section 8.1.2.8 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award.Although successor-in-interest requests may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH Grants Information grantsinfo@nih.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |